D. Abukawa, M. Nakagawa, K. Iinuma, M. Nio, R. Ohi et al., Hepatic and serum bile acid compositions in patients with biliary atresia: a microanalysis using gas chromatography-mass spectrometry with negative ion chemical ionization detection, The Tohoku journal of experimental medicine, vol.185, issue.4, pp.227-264, 1998.

E. Akaho, T. Maekawa, M. Uchinashi, and R. Kanamori, A study of streptomycin blood level information of patients undergoing hemodialysis, Biopharmaceutics & drug disposition, vol.23, issue.2, pp.47-52, 2002.

S. Antherieu, P. Bachour-el-azzi, J. Dumont, Z. Abdel-razzak, C. Guguen-guillouzo et al., Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells, Hepatology, vol.57, issue.4, pp.1518-1547, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00865999

M. S. Anwer, Role of protein kinase C isoforms in bile formation and cholestasis, Hepatology, vol.60, issue.3, pp.1090-1097, 2014.

A. Burban, A. Sharanek, C. Guguen-guillouzo, and A. Guillouzo, Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes, Free radical biology & medicine, vol.115, pp.166-178, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01671714

A. Burban, A. Sharanek, R. Hue, M. Gay, S. Routier et al., Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways, Scientific reports, vol.7, issue.1, p.1815, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01522586

M. G. Burbank, A. Burban, A. Sharanek, R. J. Weaver, C. Guguen-guillouzo et al., Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis. Drug metabolism and disposition: the biological fate of chemicals, vol.44, pp.1780-1793, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01398437

M. G. Burbank, A. Sharanek, A. Burban, H. Mialanne, H. Aerts et al., From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells, Toxicological sciences : an official journal of the Society of Toxicology, vol.157, issue.2, pp.451-464, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01558815

S. Y. Cai, X. Ouyang, Y. Chen, C. J. Soroka, J. Wang et al., Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response, JCI insight, vol.2, issue.5, p.90780, 2017.

G. Castano, S. Lucangioli, S. Sookoian, M. Mesquida, A. Lemberg et al., Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy, Clinical science, vol.110, issue.4, pp.459-65, 2006.

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, issue.4, pp.957-67, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00690471

R. Chan and L. Z. Benet, Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI, Toxicological sciences : an official journal of the Society of Toxicology, vol.162, issue.2, pp.499-508, 2018.

J. Y. Chiang, Bile acids: regulation of synthesis, Journal of lipid research, vol.50, issue.10, pp.1955-66, 2009.

S. Dawson, S. Stahl, N. Paul, J. Barber, K. et al., In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, vol.40, pp.130-138, 2012.

K. Fattinger, C. Funk, M. Pantze, C. Weber, J. Reichen et al., The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions, Clinical pharmacology and therapeutics, vol.69, issue.4, pp.223-254, 2001.

S. Fischer, U. Beuers, U. Spengler, F. M. Zwiebel, and H. G. Koebe, Hepatic levels of bile acids in end-stage chronic cholestatic liver disease, Clinica chimica acta; international journal of clinical chemistry, vol.251, issue.2, pp.173-86, 1996.

D. N. Fish and A. T. Chow, The clinical pharmacokinetics of levofloxacin, Clinical pharmacokinetics, vol.32, issue.2, pp.101-120, 1997.

Y. Fukumoto, T. Matoba, A. Ito, H. Tanaka, T. Kishi et al., Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension, Heart, vol.91, issue.3, pp.391-393, 2005.

J. C. Garcia-canaveras, M. T. Donato, J. V. Castell, and A. Lahoz, Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method, Journal of lipid research, vol.53, issue.10, pp.2231-2272, 2012.

S. J. Gardiner, P. G. Drennan, R. Begg, M. Zhang, J. K. Green et al., In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances, PloS one, vol.13, issue.7, p.199370, 2018.

H. F. Geerdes-fenge, B. Goetschi, M. Rau, K. Borner, P. Koeppe et al., Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva, European journal of clinical pharmacology, vol.53, issue.2, pp.127-160, 1997.

A. Guillouzo and C. Guguen-guillouzo, HepaRG Cells as a Model for Hepatotoxicity Studies, Stem cells in toxicology and teratology, pp.309-339, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01875339

H. Hao, L. Cao, C. Jiang, Y. Che, S. Zhang et al., Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis, Cell metabolism, vol.25, issue.4, pp.856-867, 2017.

A. F. Hofmann, Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity, Drug metabolism reviews, vol.36, issue.3-4, pp.703-725, 2004.

L. Humbert, M. A. Maubert, C. Wolf, H. Duboc, M. Mahe et al., Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients, J Chromatogr B Analyt Technol Biomed Life Sci, vol.899, pp.135-180, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00704712

T. J. Layden, . Schwarz, and J. L. Boyer, Scanning electron microscopy of the rat liver. Studies of the effect of taurolithocholate and other models of cholestasis, Gastroenterology, vol.69, issue.3, pp.724-762, 1975.

S. E. Lucangioli, G. Castano, M. D. Contin, and V. P. Tripodi, Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment, Ann Clin Biochem, vol.46, pp.44-53, 2009.

H. Malhi, M. E. Guicciardi, and G. J. Gores, Hepatocyte death: a clear and present danger, Physiological reviews, vol.90, issue.3, pp.1165-94, 2010.

M. J. Monte, J. J. Marin, A. Antelo, and J. Vazquez-tato, Bile acids: chemistry, physiology, and pathophysiology, World journal of gastroenterology, vol.15, issue.7, pp.804-820, 2009.

R. E. Morgan, M. Trauner, C. J. Van-staden, P. H. Lee, B. Ramachandran et al., , 2010.

, Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development, Toxicological sciences : an official journal of the Society of Toxicology, vol.118, issue.2, pp.485-500

A. Myara, J. F. Cadranel, R. Dorent, F. Lunel, E. Bouvier et al., Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation, Eur J Gastroenterol Hepatol, vol.8, issue.3, pp.267-71, 1996.

M. Oorts, A. Baze, P. Bachellier, B. Heyd, T. Zacharias et al., Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes, Toxicology in vitro : an international journal published in association with BIBRA, vol.34, pp.179-86, 2016.

J. M. Pedersen, P. Matsson, C. A. Bergstrom, J. Hoogstraate, A. Noren et al., Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11), Toxicological sciences : an official journal of the Society of Toxicology, vol.136, issue.2, pp.328-371, 2013.

H. Reyes and J. Sjovall, Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy, Annals of medicine, vol.32, issue.2, pp.94-106, 2000.

M. Scherer, C. Gnewuch, G. Schmitz, and G. Liebisch, Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, vol.877, issue.30, pp.3920-3925, 2009.

A. Sharanek, P. B. Azzi, H. Al-attrache, C. C. Savary, L. Humbert et al., Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells, Toxicological sciences : an official journal of the Society of Toxicology, vol.141, issue.1, pp.244-53, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01016342

A. Sharanek, A. Burban, M. Burbank, R. Le-guevel, R. Li et al., Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01326368

A. Sharanek, A. Burban, L. Humbert, P. Bachour-el-azzi, N. Felix-gomes et al., Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes, Toxicological sciences : an official journal of the Society of Toxicology, vol.147, issue.2, pp.573-87, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01187306

A. Sharanek, A. Burban, L. Humbert, C. Guguen-guillouzo, D. Rainteau et al., Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation. Drug metabolism and disposition: the biological fate of chemicals, vol.45, pp.1292-1303, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01671424

T. T. Tran, A. D. Brinker, and M. Munoz, Serious Liver Injury Associated with Macitentan: A Case Report, Pharmacotherapy, vol.38, issue.2, pp.22-24, 2018.

R. M. Tribe, A. T. Dann, A. P. Kenyon, P. Seed, A. H. Shennan et al., Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy, The American journal of gastroenterology, vol.105, issue.3, pp.585-95, 2010.

J. Trottier, A. Bialek, P. Caron, R. J. Straka, J. Heathcote et al., Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol.44, issue.4, pp.303-313, 2012.

M. Vinken, B. Landesmann, M. Goumenou, S. Vinken, I. Shah et al., Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury, Toxicological sciences : an official journal of the Society of Toxicology, vol.136, issue.1, pp.97-106, 2013.

R. Wise, J. M. Andrews, R. Matthews, and M. Wolstenholme, The in-vitro activity of two new quinolones: rufloxacin and MF 961, The Journal of antimicrobial chemotherapy, vol.29, issue.6, pp.649-60, 1992.

B. L. Woolbright, K. Dorko, D. J. Antoine, J. I. Clarke, P. Gholami et al., Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis, Toxicology and applied pharmacology, vol.283, issue.3, pp.168-77, 2015.

B. L. Woolbright, J. , and H. , Therapeutic targets for cholestatic liver injury, Expert opinion on therapeutic targets, vol.20, issue.4, pp.463-75, 2016.